Arterial Disease Multifactorial Intervention Trial (ADMIT)

NCT00000539 Phase 3 COMPLETED

To evaluate, in asymptomatic and symptomatic participants with peripheral arterial disease, the feasibility of recruitment and adherence, efficacy and safety of HDL-C raising along with effective control of LDL-C levels, antioxidant therapy, antithrombotic therapy, and their combinations.

Details

Lead sponsor	National Heart, Lung, and Blood Institute (NHLBI)
Phase	Phase 3
Status	COMPLETED
Start date	1992-09
Completion	1999-03

Conditions

• Arterial Occlusive Diseases
• Cardiovascular Diseases
• Heart Diseases
• Vascular Diseases
• Diabetes Mellitus

Interventions

• niacin
• pravastatin
• beta-carotene
• vitamin E
• dietary supplements
• vitamin C
• warfarin